Arissa Young
Physician · UCLA David Geffen School of Medicine
Credentials: · ·
History
Research
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
Immunity · 2022 · 183 citations
Hematologic Complications of Immune Checkpoint Inhibitors
The Oncologist · 2019 · 136 citations
Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus
Science Immunology · 2023 · 100 citations
5 papers
4 papers · 2 as a resident
4 papers
4 papers
3 papers
2 papers
- GW
2 papers
- HQ
2 papers
Grants
- 2024–2026
The Lipofibroblast to Myofibroblast Transition in Systemic Sclerosis
National Heart, Lung, and Blood Institute · K38
Contact PI · $221.9K · University of California Los Angeles